MedTrace Logo

Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects

NCT06653101 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-11-18

No results posted yet for this study

Summary

To assess the efficacy and safety of the use of probiotics as a food supplement compared to placebo in regulating body metabolism and gut microbiota in overweight or obese subjects.

Conditions

  • Overweight or Obesity

Interventions

DIETARY_SUPPLEMENT

Probiotic

The trial phase of this study lasted 8 weeks, and each patient will make 3 visits (week 0, week 4, week 8)

DIETARY_SUPPLEMENT

Placebo

The trial phase of this study lasted 8 weeks, and each patient will make 3 visits (week 0, week 4, week 8)

Sponsors & Collaborators

  • Wecare Probiotics Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-20
Primary Completion
2024-12-05
Completion
2025-03-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06653101 on ClinicalTrials.gov